195 related articles for article (PubMed ID: 38059214)
21. Rivaroxaban for the prevention of venous thromboembolism: a single technology appraisal.
Stevenson M; Scope A; Holmes M; Rees A; Kaltenthaler E
Health Technol Assess; 2009 Oct; 13 Suppl 3():43-8. PubMed ID: 19846028
[TBL] [Abstract][Full Text] [Related]
22. Is Enoxaparin Associated With a Higher Risk of Persistent Wound Drainage Than Aspirin? A Secondary Analysis of Data From the CRISTAL Randomized Trial.
Sidhu VS; Naylor JM; Adie S; Lieu D; Walker R; Horsley M; Kim RG; Harris IA
Clin Orthop Relat Res; 2023 Jul; 481(7):1351-1359. PubMed ID: 36649465
[TBL] [Abstract][Full Text] [Related]
23. Clinical Effectiveness and Safety of Aspirin for Venous Thromboembolism Prophylaxis After Total Hip and Knee Replacement: A Systematic Review and Meta-analysis of Randomized Clinical Trials.
Matharu GS; Kunutsor SK; Judge A; Blom AW; Whitehouse MR
JAMA Intern Med; 2020 Mar; 180(3):376-384. PubMed ID: 32011647
[TBL] [Abstract][Full Text] [Related]
24. Multimodal prophylaxis in patients with a history of venous thromboembolism undergoing primary elective hip arthroplasty.
Gonzalez Della Valle A; Shanaghan KA; Nguyen J; Liu J; Memtsoudis S; Sharrock NE; Salvati EA
Bone Joint J; 2020 Jul; 102-B(7_Supple_B):71-77. PubMed ID: 32600195
[TBL] [Abstract][Full Text] [Related]
25. Utilization Patterns, Efficacy, and Complications of Venous Thromboembolism Prophylaxis Strategies in Revision Hip and Knee Arthroplasty as Reported by American Board of Orthopaedic Surgery Part II Candidates.
Runner RP; Shau DN; Staley CA; Roberson JR
J Arthroplasty; 2021 Jul; 36(7):2364-2370. PubMed ID: 33674164
[TBL] [Abstract][Full Text] [Related]
26. Differences in Reported Outcomes in Industry-Funded vs Nonfunded Studies Assessing Thromboprophylaxis After Total Joint Arthroplasty.
Groff H; Azboy I; Parvizi J
J Arthroplasty; 2018 Nov; 33(11):3398-3401. PubMed ID: 30017220
[TBL] [Abstract][Full Text] [Related]
27. Pharmacoeconomic evaluation of dabigatran, rivaroxaban and apixaban versus enoxaparin for the prevention of venous thromboembolism after total hip or knee replacement in Spain.
Gómez-Outes A; Avendaño-Solá C; Terleira-Fernández AI; Vargas-Castrillón E
Pharmacoeconomics; 2014 Sep; 32(9):919-36. PubMed ID: 24895235
[TBL] [Abstract][Full Text] [Related]
28. Comparison of the Efficacy and Safety of Aspirin and Rivaroxaban Following Enoxaparin Treatment for Prevention of Venous Thromboembolism after Hip Fracture Surgery.
Huang Q; Xing SX; Zeng Y; Si HB; Zhou ZK; Shen B
Orthop Surg; 2019 Oct; 11(5):886-894. PubMed ID: 31663285
[TBL] [Abstract][Full Text] [Related]
29. A cost-effectiveness model comparing rivaroxaban and dabigatran etexilate with enoxaparin sodium as thromboprophylaxis after total hip and total knee replacement in the irish healthcare setting.
McCullagh L; Tilson L; Walsh C; Barry M
Pharmacoeconomics; 2009; 27(10):829-46. PubMed ID: 19803538
[TBL] [Abstract][Full Text] [Related]
30. Comparison of Postoperative Bleeding in Total Hip and Knee Arthroplasty Patients Receiving Rivaroxaban or Enoxaparin.
Ricket AL; Stewart DW; Wood RC; Cornett L; Odle B; Cluck D; Freshour J; El-Bazouni H
Ann Pharmacother; 2016 Apr; 50(4):270-5. PubMed ID: 26783354
[TBL] [Abstract][Full Text] [Related]
31. Comparison of Surgical Site Infection Risk Between Warfarin, LMWH, and Aspirin for Venous Thromboprophylaxis in TKA or THA: A Systematic Review and Meta-Analysis.
Hughes LD; Lum J; Mahfoud Z; Malik RA; Anand A; Charalambous CP
JBJS Rev; 2020 Dec; 8(12):e20.00021. PubMed ID: 33347014
[TBL] [Abstract][Full Text] [Related]
32. Comparison of Postoperative Bleeding in Total Hip and Knee Arthroplasty Patients Receiving Rivaroxaban, Enoxaparin, or Aspirin for Thromboprophylaxis.
Lindquist DE; Stewart DW; Brewster A; Waldroup C; Odle BL; Burchette JE; El-Bazouni H
Clin Appl Thromb Hemost; 2018 Nov; 24(8):1315-1321. PubMed ID: 29716395
[TBL] [Abstract][Full Text] [Related]
33. Cost-Effective Modeling of Thromboembolic Chemoprophylaxis for Total Ankle Arthroplasty.
Martinazzi BJ; Kirchner GJ; Stauch CM; Lorenz FJ; Manto KM; Bonaddio V; Koroneos Z; Aynardi MC
Foot Ankle Int; 2022 Oct; 43(10):1379-1384. PubMed ID: 35899685
[TBL] [Abstract][Full Text] [Related]
34. Incidence of silent venous thromboembolism after total hip arthroplasty: A comparison of rivaroxaban and enoxaparin.
Rahman WA; Habsa GH; Al-Mohrej OA; Hammad M; Selim NM; Hammad A
J Orthop Surg (Hong Kong); 2020; 28(2):2309499020938865. PubMed ID: 32700655
[TBL] [Abstract][Full Text] [Related]
35. No Difference Between Low- and Regular-dose Aspirin for Venous Thromboembolism Prophylaxis After THA.
Faour M; Piuzzi NS; Brigati DP; Klika AK; Mont MA; Barsoum WK; Higuera CA
Clin Orthop Relat Res; 2019 Feb; 477(2):396-402. PubMed ID: 30624322
[TBL] [Abstract][Full Text] [Related]
36. Warfarin for venous thromboembolism prophylaxis after elective hip or knee arthroplasty: exploring the evidence, guidelines, and challenges remaining.
Dager WE
Ann Pharmacother; 2012 Jan; 46(1):79-88. PubMed ID: 22202495
[TBL] [Abstract][Full Text] [Related]
37. Systematic review of aspirin for thromboprophylaxis in modern elective total hip and knee arthroplasty.
Wilson DG; Poole WE; Chauhan SK; Rogers BA
Bone Joint J; 2016 Aug; 98-B(8):1056-61. PubMed ID: 27482017
[TBL] [Abstract][Full Text] [Related]
38. Comparison of 90-Day Adverse Events Associated With Aspirin and Potent Anticoagulation Use for Venous Thromboembolism Prophylaxis: A Cohort Study of 72,288 Total Knee and 35,142 Total Hip Arthroplasty Patients.
Singh G; Prentice HA; Winston BA; Kroger EW
J Arthroplasty; 2023 Aug; 38(8):1602-1612.e1. PubMed ID: 36805118
[TBL] [Abstract][Full Text] [Related]
39. Cost-effectiveness impact of rivaroxaban versus new and existing prophylaxis for the prevention of venous thromboembolism after total hip or knee replacement surgery in France, Italy and Spain.
Monreal M; Folkerts K; Diamantopoulos A; Imberti D; Brosa M
Thromb Haemost; 2013 Nov; 110(5):987-94. PubMed ID: 23965805
[TBL] [Abstract][Full Text] [Related]
40. Aspirin for Venous Thromboembolic Prophylaxis Following Total Hip and Total Knee Arthroplasty: An Analysis of Safety and Efficacy Accounting for Surgeon Selection Bias.
Heckmann ND; Piple AS; Wang JC; Richardson MK; Mayfield CK; Oakes DA; Christ AB; Lieberman JR
J Arthroplasty; 2023 Jul; 38(7 Suppl 2):S412-S419.e1. PubMed ID: 36870517
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]